Quarterly Transactions Made in Celldex Therapeutics, Inc. (CLDX)
This table provides information about the institutional ownership of Celldex Therapeutics, Inc. (CLDX). The information is specifically focused on institutions that hold shares of Celldex Therapeutics, Inc..
Shares Purchased
Shares Sold
| Quarter | Buy | Sell | Net Activity | |||||
|---|---|---|---|---|---|---|---|---|
| New Holding | Increment | Total Shares Bought | Closed Position | Reduction | Total Shares Sold | |||
| Q4 2021 | 4,666,786 | 2,094,883 | 6,761,669 | 3,106,442 | 761,419 | 3,867,861 | 2,893,808 | |
| Q1 2022 | 7,275,664 | 1,395,292 | 8,670,956 | 3,295,438 | 1,599,871 | 4,895,309 | 3,775,647 | |
| Q2 2022 | 3,135,040 | 2,621,324 | 5,756,364 | 5,667,026 | 905,963 | 6,572,989 | -816,625 | |
| Q3 2022 | 5,931,920 | 1,989,133 | 7,921,053 | 3,622,818 | 942 | 3,623,760 | 4,297,293 | |
| Q4 2022 | 3,234,239 | 676,919 | 3,911,158 | 3,627,520 | 0 | 3,627,520 | 283,638 | |
| Q1 2023 | 3,051,870 | 1,908,051 | 4,959,921 | 3,285,443 | 5 | 3,285,448 | 1,674,473 | |
| Q2 2023 | 6,230,224 | 827,975 | 7,058,199 | 3,417,704 | 92,900 | 3,510,604 | 3,547,595 | |
| Q3 2023 | 2,918,448 | 2,141,325 | 5,059,773 | 2,702,514 | 54 | 2,702,568 | 2,357,205 | |
| Q4 2023 | 10,875,601 | 7,978,076 | 18,853,677 | 1,697,089 | 0 | 1,697,089 | 17,156,588 | |
| Q1 2024 | 13,309,405 | 11,112,810 | 24,422,215 | 4,934,732 | 0 | 4,934,732 | 19,487,483 | |
| Q2 2024 | 5,688,695 | 1,491,174 | 7,179,869 | 4,955,578 | 0 | 4,955,578 | 2,224,291 | |
| Q3 2024 | 6,767,872 | 3,249,358 | 10,017,230 | 5,978,913 | 0 | 5,978,913 | 4,038,317 | |
| Q4 2024 | 15,017 | 114,435 | 129,452 | 145 | 0 | 145 | 129,307 | |